Jun Yin

ORCID: 0000-0002-3754-9377
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Esophageal Cancer Research and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Head and Neck Cancer Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Pancreatic and Hepatic Oncology Research
  • Cancer Research and Treatments
  • Cancer Genomics and Diagnostics
  • Glioma Diagnosis and Treatment
  • Molecular Biology Techniques and Applications
  • Ferroptosis and cancer prognosis
  • Clostridium difficile and Clostridium perfringens research
  • Immune cells in cancer
  • Gut microbiota and health
  • Lung Cancer Research Studies
  • Plant Pathogens and Fungal Diseases
  • Cancer Cells and Metastasis
  • High-Temperature Coating Behaviors
  • High-Energy Particle Collisions Research
  • Essential Oils and Antimicrobial Activity
  • Technology Adoption and User Behaviour
  • Metal and Thin Film Mechanics
  • Medical Imaging Techniques and Applications
  • RNA regulation and disease
  • Digital Marketing and Social Media
  • Nutritional Studies and Diet

Nanjing Drum Tower Hospital
2024

Capital University of Physical Education and Sports
2024

University of Science and Technology of China
2024

Jiangnan University
2024

University of Electronic Science and Technology of China
2022-2023

Sichuan Cancer Hospital
2022-2023

National Engineering Research Center of Electromagnetic Radiation Control Materials
2017

American Political Science Association
1998

Abstract Neoadjuvant chemoimmunotherapy (NACI) has shown promise in the treatment of resectable esophageal squamous cell carcinoma (ESCC). The microbiomes patients can impact therapy response, and previous studies have demonstrated that intestinal microbiota influences cancer immunotherapy by activating gut immunity. Here, we investigated effects intratumoral on response with ESCC to NACI. Intratumoral signatures β-diversity were disparate predicted efficiency enrichment Streptococcus...

10.1158/0008-5472.can-22-2593 article EN Cancer Research 2023-07-11

Physical exercise is known to reduce anxiety, but the underlying brain mechanisms remain unclear. Here, we explore a hypothalamo-cerebello-amygdalar circuit that may mediate motor-dependent alleviation of anxiety. This three-neuron loop, in which cerebellar dentate nucleus takes center stage, bridges motor system with emotional system. Subjecting animals constant rotarod engages glutamatergic neurons drive PKCδ+ amygdalar elicit an anxiolytic effect. Moreover, challenging on accelerated...

10.1016/j.neuron.2024.01.007 article EN cc-by-nc Neuron 2024-01-31

Abstract The interior design suffers from inefficiency and a lack of aesthetic appeal. With the development artificial intelligence diffusion models, using text descriptions to generate aesthetically pleasing designs has emerged as new approach address these issues. In this study, we propose novel method based on model, which can quickly visually appealing input while allowing for specification decorative styles spatial functions. proposed in study creates creative drawings by computer...

10.1038/s41598-024-53318-3 article EN cc-by Scientific Reports 2024-02-12

The molecular mechanism by which inborn errors of the human RNA lariat-debranching enzyme 1 (DBR1) underlie brainstem viral encephalitis is unknown. We show here that accumulation lariats in DBR1-deficient cells interferes with stress granule (SG) assembly, promoting proteasome degradation at least G3BP1 and G3BP2, two key components SGs. In turn, impaired assembly SGs, normally recruit PKR, impairs PKR activation activity against viruses, including HSV-1. Remarkably, genetic ablation...

10.1084/jem.20240010 article EN The Journal of Experimental Medicine 2024-12-05

Background: Anlotinib is a multi-target anti-angiogenic agent. The retrospective study was conducted to evaluate the safety and effectiveness of anlotinib as monotherapy or combination therapy for treatment recurrent high-grade gliomas. Methods: In this study, patients with glioma (according 2021 World Health Organization classification levels III-IV) at Sichuan Cancer Hospital from June 2019 2022 were included. divided into an anlotinib-monotherapy group anlotinib-combination group,...

10.1177/11795549231175714 article EN cc-by-nc Clinical Medicine Insights Oncology 2023-01-01

This study investigates user experience (UX) sharing behaviors in the context of smartphone interface (UI) design, emphasizing their significance for UI enhancement and effective marketing strategies. Grounded Stimulus–Organism–Response (SOR) framework, we examine how design perception attributes—perceived usability, novelty, enjoyment, brand image—influence UX sharing, with a spotlight on mediating role individual motivation. A quantitative analysis (N = 472), Structural Equation Modeling...

10.3390/su16156670 article EN Sustainability 2024-08-04

<div>Abstract<p>Neoadjuvant chemoimmunotherapy (NACI) has shown promise in the treatment of resectable esophageal squamous cell carcinoma (ESCC). The microbiomes patients can impact therapy response, and previous studies have demonstrated that intestinal microbiota influences cancer immunotherapy by activating gut immunity. Here, we investigated effects intratumoral on response ESCC to NACI. Intra-tumoral signatures β-diversity were disparate predicted efficiency enrichment...

10.1158/0008-5472.c.6836994.v2 preprint EN 2024-09-16
Coming Soon ...